| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |